Fluicell AB
A biotech firm creating engineered tissues for regenerative medicine and drug development.
FLUI | ST
Overview
Corporate Details
- ISIN(s):
- SE0010831321 (+1 more)
- LEI:
- 549300R9LVFVFDTW5Y96
- Country:
- Sweden
- Address:
- Flöjelbergsgatan 8c, 431 37 Mölndal
- Website:
- https://fluicell.com/
Description
Fluicell is a biotechnology company focused on high-precision tissue engineering and therapeutics. The company's core technology is the Nexocyte™ platform, which leverages proprietary single-cell bioprinting and open-volume microfluidics to create precisely engineered biological tissues. The primary applications are in regenerative medicine, with an initial goal of developing transplantable tissues to treat type 1 diabetes, and in advanced drug development, providing tissue models for toxicity screening. Fluicell also commercializes a portfolio of microfluidic-based research instruments, including the BioPen and Dynaflow Resolve systems, for single-cell analysis and manipulation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Fluicell AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fluicell AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fluicell AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
